Your session is about to expire
← Back to Search
Free Light Chain Assessment in Twins
N/A
Recruiting
Led By Alan Wu, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Healthy subjects 18-80 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one month after the completion of the enrollment
Awards & highlights
Study Summary
This trial is recruiting identical and fraternal twins to help establish a reference range for free light chains in the blood.
Who is the study for?
This trial is for healthy adult twins, both identical and fraternal, aged between 18 to 80 years. Both twins need to participate. It's not open to individuals showing symptoms that might suggest they have multiple myeloma like kidney issues, low red blood cell counts (anemia), or bone pain.Check my eligibility
What is being tested?
The study involves collecting a small amount of blood from each participant at San Francisco General Hospital's Clinical Lab. The purpose is to determine the normal range for free light chains in the serum of these twins.See study design
What are the potential side effects?
Since this trial only involves drawing a small sample of blood, side effects are minimal and may include temporary discomfort at the puncture site, light-headedness, bruising or bleeding.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 80 years old and healthy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one month after the completion of the enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month after the completion of the enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Free light chain reference range
Trial Design
1Treatment groups
Experimental Treatment
Group I: Healthy twinExperimental Treatment1 Intervention
Free light chains of twins compared to non-twin siblings
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,455 Total Patients Enrolled
19 Trials studying Multiple Myeloma
1,100 Patients Enrolled for Multiple Myeloma
Alan Wu, PhDPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
450 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have symptoms like kidney issues, low blood count, or bone pain.I am between 18 and 80 years old and healthy.You must have a twin sibling, either identical or fraternal, who is also willing to participate in the study.
Research Study Groups:
This trial has the following groups:- Group 1: Healthy twin
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is it possible for me to be a part of this experimental research?
"To qualify for this trial, applicants must have multiple myeloma and be aged between 18 and 80 years. A total of 100 people are needed to complete the experimental cohort."
Answered by AI
Do participants in this research need to be below a certain age threshold?
"According to the parameters of this trial, individuals aged 18 or older and younger than 80 are eligible for enrollment."
Answered by AI
Is recruitment for this trial still open?
"Affirmative. According to clinicaltrials.gov, this research initiative is accepting applications, having first become available on August 15th 2018 and being last updated on March 23rd 2022. The trial requires 100 participants from 1 medical facility."
Answered by AI
How many participants are currently running the experiment?
"Correct. According to clinicaltrials.gov, the trial first opened on August 15th 2018 and is inviting applicants now. The research requires 100 participants from a single site to take part in the study."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger